Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.


BACKGROUND This study was performed to evaluate antithrombin III levels in postmenopausal women receiving hormonal replacement treatment. METHODS It is a prospective randomized study concerning 19 postmenopausal patients, aged 40 to 65 years, who received either continuous daily oral equine conjugated estrogen 0.625 mg (group A, N=10) or daily transdermal… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics